Sudha Rao
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 11, 2025
Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.Michelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann
|Jun 27, 2023
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting.Wen Juan Tu, Michelle Melino, Jenny Dunn
|Mar 25, 2022
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers.Jenny Dunn, Robert D McCuaig, Abel H Y Tan
|Sep 20, 2018
Optimizing poly (ADP-ribose) polymerase inhibition through combined epigenetic and immunotherapy.Thiru Prasanna, Fan Wu, Kum Kum Khanna
|May 07, 2016
Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+ T cells through p65 and H2B phosphorylation.Jasmine Li, Kristine Hardy, Chan Phetsouphanh
Pageof 1
Frequent Collaborators
2 joint publications
Jane E Dahlstrom
2 joint publications
Desmond Yip
2 joint publications
Helle Bielefeldt-Ohmann
2 joint publications
John Vandermeide
1 joint publications
Fan Wu
1 joint publications
David A Jans
1 joint publications
Jade K Forwood
1 joint publications
Yan Liang
1 joint publications
Katie Lineburg
1 joint publications
Julian D J Sng
